Sotera Health Co
NASDAQ:SHC

Watchlist Manager
Sotera Health Co Logo
Sotera Health Co
NASDAQ:SHC
Watchlist
Price: 13.33 USD 0.68% Market Closed
Market Cap: 3.8B USD
Have any thoughts about
Sotera Health Co?
Write Note

Wall Street
Price Targets

SHC Price Targets Summary
Sotera Health Co

Wall Street analysts forecast SHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHC is 16.51 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

Lowest
Price Target
13.13 USD
2% Downside
Average
Price Target
16.51 USD
24% Upside
Highest
Price Target
21 USD
58% Upside

SHC Last Price Targets
Sotera Health Co

The latest public price target was made on Nov 6, 2024 by David Windley from Jefferies , who expects SHC stock to rise by 35% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Windley
Jefferies
18 USD
Upside 35%
1 month ago
Nov 6, 2024
Sotera Health (SHC) PT Raised to $18 at Jefferies
StreetInsider
Luke Sergott
Barclays
17 USD
Upside 28%
4 months ago
Aug 6, 2024
Sotera Health price target raised to $17 from $14 at Barclays
TheFly
David Windley
Jefferies
14.5 USD
Upside 9%
6 months ago
Jun 6, 2024
Sotera Health (SHC) PT Raised to $14.50 at Jefferies
StreetInsider
Jason Bednar
Piper Sandler
13 USD
Downside 2%
7 months ago
May 21, 2024
Piper Sandler Starts Sotera Health (SHC) at Neutral
StreetInsider
Sean Dodge
RBC Capital
17 USD
Upside 28%
7 months ago
May 3, 2024
Sotera Health (SHC) PT Lowered to $17 at RBC Capital
StreetInsider
Luke Sergott
Barclays
14 USD
Upside 5%
8 months ago
Apr 10, 2024
Sotera Health price target lowered to $14 from $19 at Barclays
TheFly
David Windley
Jefferies
15.5 USD
Upside 16%
8 months ago
Mar 25, 2024
Jefferies Upgrades Sotera Health (SHC) to Buy
StreetInsider
Matthew Mishan
Loop Capital Markets
24 USD
Upside 80%
1 year ago
Jun 26, 2023
Analyst Upgrades Sotera Health Shares To Overweight, Cites Strong Revenue Growth Outlook
Benzinga
Show More Price Targets
Show Less Price Targets
David Windley
Jefferies
Price Target 18 USD
Upside/Downside 35%
View Source
Luke Sergott
Barclays
Price Target 17 USD
Upside/Downside 28%
View Source
David Windley
Jefferies
Price Target 14.5 USD
Upside/Downside 9%
View Source
Jason Bednar
Piper Sandler
Price Target 13 USD
Upside/Downside 2%
View Source
Sean Dodge
RBC Capital
Price Target 17 USD
Upside/Downside 28%
View Source
Luke Sergott
Barclays
Price Target 14 USD
Upside/Downside 5%
View Source
David Windley
Jefferies
Price Target 15.5 USD
Upside/Downside 16%
View Source
Matthew Mishan
Loop Capital Markets
Price Target 24 USD
Upside/Downside 80%
View Source
Show More Price Targets
Show Less Price Targets
Sotera Health Co Competitors:
Price Targets
WST
West Pharmaceutical Services Inc
14% Upside
300463
Maccura Biotechnology Co Ltd
4% Upside
MTD
Mettler-Toledo International Inc
12% Upside
ILMN
Illumina Inc
23% Upside
BIO
Bio Rad Laboratories Inc
24% Upside
DHR
Danaher Corp
28% Upside
MXCT
MaxCyte Inc
132% Upside
TMO
Thermo Fisher Scientific Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Sotera Health Co

For the last 4 years the compound annual growth rate for Sotera Health Co's revenue is 8%. The projected CAGR for the next 4 years is 7%.

8%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sotera Health Co

For the last 4 years the compound annual growth rate for Sotera Health Co's operating income is 10%. The projected CAGR for the next 3 years is 26%.

10%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-38%
Average Miss

Net Income
Forecast

Net Income Estimate
Sotera Health Co

The compound annual growth rate of Sotera Health Co's net income for the next 3 years is 71%.

N/A
Past Growth
71%
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SHC's stock price target?
Price Target
16.51 USD

According to Wall Street analysts, the average 1-year price target for SHC is 16.51 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

What is Sotera Health Co's Revenue forecast?
Projected CAGR
7%

For the last 4 years the compound annual growth rate for Sotera Health Co's revenue is 8%. The projected CAGR for the next 4 years is 7%.

What is Sotera Health Co's Operating Income forecast?
Projected CAGR
26%

For the last 4 years the compound annual growth rate for Sotera Health Co's operating income is 10%. The projected CAGR for the next 3 years is 26%.

What is Sotera Health Co's Net Income forecast?
Projected CAGR
71%

The compound annual growth rate of Sotera Health Co's net income for the next 3 years is 71%.

Back to Top